Early treatment of central serous retinopathy by photodynamic therapy. A randomized controlled trial.
Phase 3
Completed
- Conditions
- central serous retinopathy10047060
- Registration Number
- NL-OMON45189
- Lead Sponsor
- Oogziekenhuis Rotterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Age > 18 years.
Informed consent.
Poor prognositic acute CSR.
Exclusion Criteria
History of CSR in either eye.
Allergy to fluorescein dyes.
Allergy to visudyne.
Opaque ocular media, impairing regular fundus imaging
Other ocular disorder possibly reducing visual acuity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Visual acuity at 1 year.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Metamorphopsia, color vision, recurrence, presence of persistent subretinal<br /><br>fluid on OCT, lesion size on autofluorescence imaging.</p><br>